...
search icon
dbvt-img

DBV Technologies, Common Stock

DBVT

NAQ

$4.87

-$0.34

(-6.53%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$99.92M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
18.41K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.92
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.2 L
$8.32 H
$4.87

About DBV Technologies, Common Stock

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameDBVTSectorS&P500
1-Week Return16.63%-3.65%-4.24%
1-Month Return10.81%-0.67%-9.57%
3-Month Return51.24%3.24%-9.1%
6-Month Return29.87%-8.53%-1.99%
1-Year Return-40.09%-1.45%7.14%
3-Year Return-64.19%10.77%32.27%
5-Year Return-90.74%76%131.99%
10-Year Return-97.71%95.95%164.94%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue14.71M11.28M5.71M4.80M15.73M[{"date":"2019-12-31","value":93.51,"profit":true},{"date":"2020-12-31","value":71.69,"profit":true},{"date":"2021-12-31","value":36.29,"profit":true},{"date":"2022-12-31","value":30.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue144.98M18.82M9.27M20.30M(4.16M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":12.98,"profit":true},{"date":"2021-12-31","value":6.4,"profit":true},{"date":"2022-12-31","value":14,"profit":true},{"date":"2023-12-31","value":-2.87,"profit":false}]
Gross Profit(130.28M)(18.82M)(3.57M)(15.50M)15.73M[{"date":"2019-12-31","value":-828.3,"profit":false},{"date":"2020-12-31","value":-119.64,"profit":false},{"date":"2021-12-31","value":-22.67,"profit":false},{"date":"2022-12-31","value":-98.55,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(885.74%)(166.88%)(62.46%)(322.90%)100.00%[{"date":"2019-12-31","value":-885.74,"profit":false},{"date":"2020-12-31","value":-166.88,"profit":false},{"date":"2021-12-31","value":-62.46,"profit":false},{"date":"2022-12-31","value":-322.9,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses169.93M165.92M105.24M101.40M92.16M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":97.64,"profit":true},{"date":"2021-12-31","value":61.93,"profit":true},{"date":"2022-12-31","value":59.67,"profit":true},{"date":"2023-12-31","value":54.24,"profit":true}]
Operating Income(169.93M)(194.80M)(98.61M)(96.63M)(76.43M)[{"date":"2019-12-31","value":-16993010126,"profit":false},{"date":"2020-12-31","value":-19479866600,"profit":false},{"date":"2021-12-31","value":-9861400000,"profit":false},{"date":"2022-12-31","value":-9663100000,"profit":false},{"date":"2023-12-31","value":-7643300000,"profit":false}]
Total Non-Operating Income/Expense(2.84M)(25.39M)9.41M858.00K5.46M[{"date":"2019-12-31","value":-30.22,"profit":false},{"date":"2020-12-31","value":-269.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.12,"profit":true},{"date":"2023-12-31","value":57.98,"profit":true}]
Pre-Tax Income(171.43M)(195.69M)(98.19M)(96.20M)(72.72M)[{"date":"2019-12-31","value":-17143225199,"profit":false},{"date":"2020-12-31","value":-19569023500,"profit":false},{"date":"2021-12-31","value":-9819000000,"profit":false},{"date":"2022-12-31","value":-9620000000,"profit":false},{"date":"2023-12-31","value":-7271900000,"profit":false}]
Income Taxes610.49K(12.26K)(381.00K)100.00K7.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-2.01,"profit":false},{"date":"2021-12-31","value":-62.41,"profit":false},{"date":"2022-12-31","value":16.38,"profit":true},{"date":"2023-12-31","value":1.15,"profit":true}]
Income After Taxes(172.04M)(195.68M)(97.81M)(96.30M)(72.73M)[{"date":"2019-12-31","value":-17204274499,"profit":false},{"date":"2020-12-31","value":-19567797133,"profit":false},{"date":"2021-12-31","value":-9780900000,"profit":false},{"date":"2022-12-31","value":-9630000000,"profit":false},{"date":"2023-12-31","value":-7272600000,"profit":false}]
Income From Continuous Operations(153.59M)(159.56M)(97.81M)(96.27M)(100.78M)[{"date":"2019-12-31","value":-15358700000,"profit":false},{"date":"2020-12-31","value":-15955500000,"profit":false},{"date":"2021-12-31","value":-9780900000,"profit":false},{"date":"2022-12-31","value":-9627400000,"profit":false},{"date":"2023-12-31","value":-10078100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(172.04M)(195.68M)(97.81M)(96.30M)(72.73M)[{"date":"2019-12-31","value":-17204274577,"profit":false},{"date":"2020-12-31","value":-19567797100,"profit":false},{"date":"2021-12-31","value":-9780900000,"profit":false},{"date":"2022-12-31","value":-9630000000,"profit":false},{"date":"2023-12-31","value":-7272600000,"profit":false}]
EPS (Diluted)0.18(2.95)(0.80)(1.22)(0.48)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1638.89,"profit":false},{"date":"2021-12-31","value":-444.44,"profit":false},{"date":"2022-12-31","value":-677.78,"profit":false},{"date":"2023-12-31","value":-265.61,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DBVT
Cash Ratio 1.50
Current Ratio 2.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DBVT
ROA (LTM) -46.25%
ROE (LTM) -103.11%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DBVT
Debt Ratio Lower is generally better. Negative is bad. 0.42
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.58

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DBVT
Trailing PE NM
Forward PE NM
P/S (TTM) 7.98
P/B 1.85
Price/FCF NM
EV/R 0.00
EV/Ebitda NM
PEG NM

FAQs

What is DBV Technologies share price today?

DBV Technologies (DBVT) share price today is $4.87

Can Indians buy DBV Technologies shares?

Yes, Indians can buy shares of DBV Technologies (DBVT) on Vested. To buy DBV Technologies from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DBVT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of DBV Technologies be purchased?

Yes, you can purchase fractional shares of DBV Technologies (DBVT) via the Vested app. You can start investing in DBV Technologies (DBVT) with a minimum investment of $1.

How to invest in DBV Technologies shares from India?

You can invest in shares of DBV Technologies (DBVT) via Vested in three simple steps:

  • Click on Sign Up or Invest in DBVT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in DBV Technologies shares
What is DBV Technologies 52-week high and low stock price?

The 52-week high price of DBV Technologies (DBVT) is $8.32. The 52-week low price of DBV Technologies (DBVT) is $2.2.

What is DBV Technologies price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of DBV Technologies (DBVT) is 1.85

What is the Market Cap of DBV Technologies?

The market capitalization of DBV Technologies (DBVT) is $99.92M

What is DBV Technologies’s stock symbol?

The stock symbol (or ticker) of DBV Technologies is DBVT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top